POZEN, Inc. (NASDAQ:POZN)

CAPS Rating: 3 out of 5

A pharmaceutical company focused on developing products which can provide improved efficacy, safety or patient convenience in the treatment of acute and chronic pain and pain related conditions.

Recs

1
Player Avatar Haugurafpeningum (81.72) Submitted: 11/8/2011 2:29:35 AM : Outperform Start Price: $2.66 POZN Score: +128.89

Technical Monthly

Featured Broker Partners


Advertisement